Tags: Lilly | Drop | Profit | drug

Lilly Projects Sharp Drop in 2012 Profit

Thursday, 05 Jan 2012 08:26 AM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink

Eli Lilly & Co. forecast a steeper-than-expected decline in profit for 2012, the first full year without exclusive rights to its big-selling Zyprexa schizophrenia treatment.

Shares fell 3.5 percent after Lilly announced its forecast on Thursday.

The drugmaker projected earnings in the range of $3.10 per share to $3.20 per share for 2012. For 2011, Lilly said it expects to meet or exceed its profit forecast of $4.30 per share to $4.35 per share, excluding items. Including items, Lilly sees 2011 earnings per share of $3.84 to $3.89.

Analysts were looking for $3.61 per share in 2012, according to Thomson Reuters I/B/E/S.

Zyprexa, a $4.5 billion-a-year product, began facing competition in October from low-cost generic versions in the United States.

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Retype Email:
Country
Zip Code:
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
You May Also Like

Quinnipiac Poll: Hillary More Popular Than Gov. Kasich in Ohio

Friday, 01 Aug 2014 18:51 PM

Despite President Barack Obama's abysmal approval rating with Ohio voters, fellow Democrat Hillary Clinton is a more pop . . .

Reports: Cruz Angering GOP Establishment on Way to '16 Run

Friday, 01 Aug 2014 17:55 PM

Sen. Ted Cruz has his eye fixed on the White House, and he plans to undercut the established Republican House leadership . . .

Gallup Poll: Midterms Look Grim for Democrats

Friday, 01 Aug 2014 12:16 PM

Slightly more Americans identify politically as being Democrats than Republicans, but that isn't enough to overcome vote . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved